The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 03, 2017

Filed:

Aug. 10, 2011
Applicants:

Takao Anzai, Kanagawa, JP;

Atsuhiko Nogawa, Kanagawa, JP;

Yuichi Tada, Kanagawa, JP;

Inventors:

Takao Anzai, Kanagawa, JP;

Atsuhiko Nogawa, Kanagawa, JP;

Yuichi Tada, Kanagawa, JP;

Assignee:

Terumo Kabushiki Kaisha, Shibuya-Ku, Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 24/10 (2006.01); A61L 24/06 (2006.01); A61L 24/08 (2006.01); A61M 16/04 (2006.01); A61K 9/00 (2006.01); A61L 31/04 (2006.01); A61L 31/14 (2006.01); A61B 17/12 (2006.01); A61M 25/10 (2013.01);
U.S. Cl.
CPC ...
A61L 24/104 (2013.01); A61B 17/12181 (2013.01); A61K 9/007 (2013.01); A61L 24/06 (2013.01); A61L 24/08 (2013.01); A61L 31/042 (2013.01); A61L 31/145 (2013.01); A61M 16/04 (2013.01); A61M 16/0404 (2014.02); A61B 17/12045 (2013.01); A61L 2430/36 (2013.01); A61M 2025/1052 (2013.01); A61M 2202/0007 (2013.01); A61M 2202/0208 (2013.01); A61M 2202/0225 (2013.01); A61M 2202/0488 (2013.01); A61M 2202/064 (2013.01); A61M 2210/1039 (2013.01);
Abstract

The invention has as its object the provision of a medicine capable of reducing a volume of emphysema-suffering pulmonary alveoli or alveolar sacs by means of a respiratory region volume inhibitor containing a coating film formation as a main component and capable of forming a coating film in a respiratory region, characterized by being used in such a way that the coating film-forming component is administered to an emphysema-suffering pulmonary alveolar parenchyma in a human-respiratory region in an amount of 0.004 to 200 g/application, preferably 0.07 to 20 g/application and more preferably 0.5 to 5 g/application on each occasion.


Find Patent Forward Citations

Loading…